Trials / Completed
CompletedNCT05287633
Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- University of Monastir · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
evaluate the interest of proton pump inhibitors in subjects with or with GI symptoms who intend to observe fasting in Ramadan. The investigators will compare the effectiveness of proton pump inhibitors to prevent or reduce the signs of dyspepsia during Ramadan compared to placebo.
Detailed description
evaluate the interest of proton pump inhibitors in subjects with or with GI symptoms who intend to observe fasting in Ramadan. Investigators will compare the effectiveness of proton pump inhibitors to prevent or reduce the signs of dyspepsia during at least Ramadan compared to placebo. The study will be conducted at least from April 2019 to at least June 2030.The study is prospective, two parallel groups, randomized controlled and double blind.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | Patients are given a box of capsules of which they take 1capsule/day during the month of ramadan |
| DRUG | Placebo | Patients are given a box of capsules of which they take 1capsule/day during the month of ramadan |
Timeline
- Start date
- 2020-01-20
- Primary completion
- 2020-12-15
- Completion
- 2024-12-30
- First posted
- 2022-03-18
- Last updated
- 2025-02-25
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT05287633. Inclusion in this directory is not an endorsement.